Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial.
Reis G, Augusto Dos Santos Moreira Silva E, Carla Medeiros Silva D, Thabane L, Santiago Ferreira T, Vitor Quirino Dos Santos C, Paula Figueiredo Guimaraes Almeida A, Cançado Monteiro Savassi L, Dias de Figueiredo Neto A, Lanna França Reis L, Helena de Souza Campos V, Bitarães C, Diniz Callegari E, Izabel Campos Simplicio M, Barra Ribeiro L, Oliveira R, Harari O, Forrest JI, Lat PK, Dron L, Thorlund K, Mills EJ.
Reis G, et al.
Am J Clin Nutr. 2024 Sep;120(3):602-609. doi: 10.1016/j.ajcnut.2024.06.016. Epub 2024 Aug 15.
Am J Clin Nutr. 2024.
PMID: 39232602
Free article.
Clinical Trial.
BACKGROUND: Algae-derived nutraceuticals, such as spirulina, have been reported to have biological activities that may minimize clinical consequences to COVID-19 infections. ...The primary end point was hospitalization defined as either retention in a COVI …
BACKGROUND: Algae-derived nutraceuticals, such as spirulina, have been reported to have biological activities that may minimize clini …